Back on the good ship Hemo!10 Nov 2020 17:36
I am back albeit with a much reduced holding but enough that I am comfortable now.
Did not feel comfortable atall this past weeks being in other stocks with news due so soon with Hemogenyx.
Personally I am surprised there has been no news on the final tests on SAFE-HEMO-CAR-T or including it in the agreement with Penn, I was previously willing to accept that I would miss that bounce but it would not be too significant, but from todays prices its going to be much bigger.
Then there is CDX. The previous delays have been 3 more months, 3 more months to licence, very unclear and poorly communicated. Basically before it was "Eli labs are shut, we dont know when it will start up again, so delaying for 3 months"
NOW we know Eli labs are up and running and selecting one antibody from a pool of options to licence.
When I read that again in a better mind frame a few things came to me... Hemo have MULTIPLE working candidates???? Eli are only licencing one of them but presumably there are others that also work? How many??? Can other companies licence CDX also now? Irrelevant at this point.
They are selecting ONE so I can only guess they have say 21 mice, 3 candidates, treat 7 with each, see which batch shows the best results in quickest time? Not sure how they select but you must presume there is some metric like this which has a fixed duration, when its done its science, one wins, the others are ruled out, write the name on what we can only presume is a licencing agreement and sign! Boom, possibly december 2020 for inflection point as predicted!